Northwest Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-663
Closed -$44.6K 131
2025
Q3
$44.6K Hold
663
0.05% 124
2025
Q2
$57.9K Hold
663
0.03% 158
2025
Q1
$45.3K Hold
663
0.02% 196
2024
Q4
$51.6K Hold
663
0.02% 185
2024
Q3
$44.4K Hold
663
0.02% 200
2024
Q2
$75.2K Hold
663
0.03% 168
2024
Q1
$92K Hold
663
0.03% 181
2023
Q4
$82.3K Hold
663
0.03% 182
2023
Q3
$61.9K Buy
+663
New +$74.7K 0.02% 191

Other funds holding DXCM

Northwest Capital Management's DXCM Position: Q4 2025 in Review

Northwest Capital Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 663 shares — an estimated $44.6K sold.

Northwest Capital Management first reported a position in DXCM in Q3 2023 and held it in 9 quarters. The position peaked at $92K in Q1 2024. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Northwest Capital Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Northwest Capital Management sold 663 DexCom shares in Q4 2025, an estimated $44.6K.
  • Northwest Capital Management first reported a position in DexCom in Q3 2023 and held it in 9 quarters.
  • Northwest Capital Management's DexCom position peaked at $92K in Q1 2024.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Northwest Capital Management's 13F filing for Q4 2025, filed 26 Jan 2026.